This report describes the novel design features and first-in-man experience of the second-generation Amplatzer Cardiac Plug (Amulet) for left atrial appendage occlusion.
Answers are grounded in this paper and cite their sources.
Initial Amulet experience is hypothesis-generating; larger prospective trials needed before clinical consideration.
Percutaneous left atrial appendage (LAA) closure is becoming a frequently performed procedure for patients with atrial fibrillation and high haemorrhagic risk. The Amplatzer™ Cardiac Plug (ACP) is one of the most commonly used devices for this purpose. Despite high success rate and low procedure risk associated with the ACP, a second generation of the device is now available. The new ACP has been designed to facilitate the implantation process, improve sealing performance and further reduce the risk of complications. The present report focuses on the novel features of the second generation of the Amplatzer™ Cardiac Plug (ACP 2 or Amulet™) and describes the first-in-man experience.
No takes yet. Share an insight, caveat, or question.
Freixa et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: